Related Experiment Video
Updated: Aug 25, 2026

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
Circadian timing in cancer treatment: the biological foundation for an integrative approach
Christopher G Lis1, James F Grutsch, Patricia Wood
1Cancer Treatment Centers of America, Midwestern Regional Medical Center, Zion, IL 60099, USA. christopher.lis@mrmc-ctca.com
Abstract:
Despite the many innovations that have occurred in cancer treatment, the age-specific mortality for most adult tumors has remained stable during the past 30 years. There have been clinically significant improvements in the outcomes of young and middle-aged patients, yet the vast majority of cancer patients are more than 50 years of age, among whom we observe few improvements in clinical outcomes. Clearly, many of today's cytotoxic agents have been shown to be effective in-vitro and in animal model systems; however, few have proved efficacious in dramatically improving survival outcomes in adult cancer. There is now increasing evidence to suggest that the administration of cytotoxic agents, at the appropriate circadian phase, can significantly increase the therapeutic index of current cancer therapies.
Insights
Cancer treatment outcomes for patients over 50 remain poor. Timed administration of chemotherapy, known as chronochemotherapy, may improve survival by increasing treatment efficacy and reducing toxicity.
Area of Science:
- Oncology
- Chronobiology
- Pharmacology
Background:
- Cancer mortality rates for adults over 50 have stagnated despite treatment advancements.
- Current cytotoxic chemotherapy shows limited efficacy in improving survival for the majority of adult cancer patients.
- Existing treatments are often ineffective in dramatically improving survival outcomes in adult cancers.
Purpose of the Study:
- To investigate the potential of circadian-timed chemotherapy to enhance cancer treatment efficacy.
- To explore increasing evidence suggesting improved therapeutic index with phase-specific cytotoxic agent administration.
Main Methods:
- Review of existing evidence on chronochemotherapy.
- Analysis of in-vitro and animal model data for cytotoxic agents.
- Evaluation of clinical outcomes related to timed drug administration.
Main Results:
- Cytotoxic agents demonstrate in-vitro and in-vivo efficacy.
- Few agents have significantly improved adult cancer survival rates.
- Evidence suggests phase-specific administration can increase the therapeutic index.
Conclusions:
- Circadian-timed chemotherapy offers a promising strategy to improve cancer treatment outcomes.
- Optimizing drug administration timing can enhance the efficacy of current therapies.
- Further research into chronochemotherapy is warranted for adult cancer patients.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
